Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -98,260 | 5,865 | -41,811 | -176,494 | -90,552 |
| Depreciation Amortization | 7,604 | 5,276 | 3,379 | 13,331 | 9,774 |
| Accounts receivable | 164 | -68,024 | -38,157 | 8,845 | 10,016 |
| Accounts payable and accrued liabilities | 5,001 | 6,688 | -2,072 | -6,589 | -3,563 |
| Other Working Capital | -110,321 | -166,236 | -59,323 | -98,293 | -84,068 |
| Other Operating Activity | 67,848 | 109,244 | 62,468 | 123,069 | 90,999 |
| Operating Cash Flow | $-127,964 | $-107,187 | $-75,516 | $-136,131 | $-67,394 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -13,834 | -50,534 | -111,199 | -223,391 | -21,796 |
| PPE Investments | -112,830 | -66,225 | -38,911 | -52,777 | -20,066 |
| Sale Of Investment | N/A | N/A | 69,416 | 270,751 | N/A |
| Investing Cash Flow | $-126,664 | $-116,759 | $-80,694 | $-5,417 | $-41,862 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 60,000 | 60,000 |
| Common Stock Issued | 2,232 | 1,096 | 576 | 5,186 | 4,331 |
| Other Financing Activity | 250,000 | 250,000 | 250,000 | 0 | 0 |
| Financing Cash Flow | $252,232 | $251,096 | $250,576 | $65,186 | $64,331 |
| Exchange Rate Effect | -275 | -196 | -122 | -67 | -70 |
| Beginning Cash Position | 108,005 | 108,005 | 108,005 | 184,434 | 184,434 |
| End Cash Position | 105,334 | 134,959 | 202,249 | 108,005 | 139,439 |
| Net Cash Flow | $-2,671 | $26,954 | $94,244 | $-76,429 | $-44,995 |
| Free Cash Flow | |||||
| Operating Cash Flow | -127,964 | -107,187 | -75,516 | -136,131 | -67,394 |
| Capital Expenditure | -112,830 | -66,225 | -38,911 | -52,777 | -20,066 |
| Free Cash Flow | -240,794 | -173,412 | -114,427 | -188,908 | -87,460 |